Olivier et al. [27] hypothesize that p53 mutations (mp p53) are associated with decreased expression of thrombospondin 1 (TSP-1) and that decreased TSP-1 expression is associated with lymph node metastases. The gene discussed is TP53; the disease is metastatic malignant neoplasm in the lymph nodes.